vs
NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP（NRUC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP的1.4倍（$75.5M vs $53.8M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -52.7%），NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP自由现金流更多（$105.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -1.5%）
美国国家农村公用事业合作金融公司（CFC）是一家由成员所有的非盈利合作社，为美国农村电力合作网络提供金融产品。该公司成立于1969年，创立初衷是从资本市场筹集资金，补充美国农业部农村公用事业局面向电力合作社的贷款项目。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NRUC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$53.8M
营收增速更快
PBYI
高出80.4%
-52.7%
自由现金流更多
NRUC
多$90.7M
$14.4M
两年增速更快
PBYI
近两年复合增速
-1.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.8M | $75.5M |
| 净利润 | $22.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 41.6% | — |
| 营收同比 | -52.7% | 27.7% |
| 净利润同比 | -74.0% | — |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NRUCPBYI
| Q1 26 | $53.8M | — | ||
| Q4 25 | $59.0M | $75.5M | ||
| Q3 25 | $47.3M | $54.5M | ||
| Q2 25 | $66.9M | $52.4M | ||
| Q1 25 | $113.7M | $46.0M | ||
| Q4 24 | $182.0M | $59.1M | ||
| Q3 24 | $61.7M | $80.5M | ||
| Q2 24 | — | $47.1M |
净利润NRUCPBYI
| Q1 26 | $22.4M | — | ||
| Q4 25 | $19.6M | — | ||
| Q3 25 | $4.8M | $8.8M | ||
| Q2 25 | $73.1M | $5.9M | ||
| Q1 25 | $86.0M | $3.0M | ||
| Q4 24 | $144.4M | — | ||
| Q3 24 | $-163.8M | $20.3M | ||
| Q2 24 | — | $-4.5M |
毛利率NRUCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率NRUCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% |
净利率NRUCPBYI
| Q1 26 | 41.6% | — | ||
| Q4 25 | 33.2% | — | ||
| Q3 25 | 10.1% | 16.2% | ||
| Q2 25 | 109.3% | 11.2% | ||
| Q1 25 | 75.6% | 6.5% | ||
| Q4 24 | 79.4% | — | ||
| Q3 24 | -265.7% | 25.2% | ||
| Q2 24 | — | -9.6% |
每股收益（稀释后）NRUCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $240.7M | $97.5M |
| 总债务越低越好 | $28.9B | $22.7M |
| 股东权益账面价值 | $3.1B | $130.3M |
| 总资产 | $39.9B | $216.3M |
| 负债/权益比越低杠杆越低 | 9.40× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NRUCPBYI
| Q1 26 | $240.7M | — | ||
| Q4 25 | $304.5M | $97.5M | ||
| Q3 25 | $257.1M | $94.4M | ||
| Q2 25 | $134.7M | $96.0M | ||
| Q1 25 | $245.4M | $93.2M | ||
| Q4 24 | $347.1M | $101.0M | ||
| Q3 24 | $264.7M | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务NRUCPBYI
| Q1 26 | $28.9B | — | ||
| Q4 25 | $27.3B | $22.7M | ||
| Q3 25 | $27.9B | $34.0M | ||
| Q2 25 | $27.2B | $45.3M | ||
| Q1 25 | $27.5B | $56.7M | ||
| Q4 24 | $26.7B | $68.0M | ||
| Q3 24 | $26.3B | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益NRUCPBYI
| Q1 26 | $3.1B | — | ||
| Q4 25 | $3.1B | $130.3M | ||
| Q3 25 | $3.0B | $115.3M | ||
| Q2 25 | $3.1B | $104.7M | ||
| Q1 25 | $3.0B | $97.1M | ||
| Q4 24 | $2.9B | $92.1M | ||
| Q3 24 | $2.8B | $71.1M | ||
| Q2 24 | — | $48.5M |
总资产NRUCPBYI
| Q1 26 | $39.9B | — | ||
| Q4 25 | $39.1B | $216.3M | ||
| Q3 25 | $38.8B | $202.9M | ||
| Q2 25 | $38.3B | $194.9M | ||
| Q1 25 | $37.8B | $196.2M | ||
| Q4 24 | $37.1B | $213.3M | ||
| Q3 24 | $36.5B | $220.7M | ||
| Q2 24 | — | $205.0M |
负债/权益比NRUCPBYI
| Q1 26 | 9.40× | — | ||
| Q4 25 | 8.95× | 0.17× | ||
| Q3 25 | 9.21× | 0.30× | ||
| Q2 25 | 8.81× | 0.43× | ||
| Q1 25 | 9.15× | 0.58× | ||
| Q4 24 | 9.14× | 0.74× | ||
| Q3 24 | 9.44× | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $105.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $105.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 195.2% | 19.1% |
| 资本支出强度资本支出/营收 | 0.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.72× | — |
| 过去12个月自由现金流最近4个季度 | $428.2M | $41.7M |
8季度趋势，按日历期对齐
经营现金流NRUCPBYI
| Q1 26 | $105.6M | — | ||
| Q4 25 | $38.9M | $14.4M | ||
| Q3 25 | $82.3M | $9.7M | ||
| Q2 25 | $207.5M | $14.1M | ||
| Q1 25 | $150.3M | $3.6M | ||
| Q4 24 | $63.8M | $15.6M | ||
| Q3 24 | $36.7M | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流NRUCPBYI
| Q1 26 | $105.1M | — | ||
| Q4 25 | $38.3M | $14.4M | ||
| Q3 25 | $82.0M | $9.7M | ||
| Q2 25 | $202.8M | $14.1M | ||
| Q1 25 | $149.0M | $3.6M | ||
| Q4 24 | $62.7M | $15.6M | ||
| Q3 24 | $35.4M | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率NRUCPBYI
| Q1 26 | 195.2% | — | ||
| Q4 25 | 64.9% | 19.1% | ||
| Q3 25 | 173.4% | 17.7% | ||
| Q2 25 | 303.1% | 26.8% | ||
| Q1 25 | 131.0% | 7.7% | ||
| Q4 24 | 34.5% | 26.4% | ||
| Q3 24 | 57.5% | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度NRUCPBYI
| Q1 26 | 0.9% | — | ||
| Q4 25 | 1.1% | 0.0% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 7.0% | 0.0% | ||
| Q1 25 | 1.1% | 0.1% | ||
| Q4 24 | 0.6% | 0.0% | ||
| Q3 24 | 2.1% | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率NRUCPBYI
| Q1 26 | 4.72× | — | ||
| Q4 25 | 1.99× | — | ||
| Q3 25 | 17.27× | 1.10× | ||
| Q2 25 | 2.84× | 2.41× | ||
| Q1 25 | 1.75× | 1.21× | ||
| Q4 24 | 0.44× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
